MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
53.95
-0.93 (-1.69%)
At close: Aug 15, 2025, 3:04 PM

MoonLake Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.38M 13.16K 12.36K 4.97K
Gross Profit
-1.38M -13.16K -12.36K -4.97K
Operating Income
-143.09M -54.12M -65.06M -53.58M
Interest Income
n/a n/a n/a n/a
Pretax Income
-120.96M -43.98M -64.47M -53.64M
Net Income
-118.94M -36.01M -64.51M -53.64M
Selling & General & Admin
30.32M 22.32M 23.01M 18.05M
Research & Development
111.39M 31.79M 42.05M 35.52M
Other Expenses
1.38M n/a 591.73K n/a
Operating Expenses
143.09M 54.12M 65.06M 53.57M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
-30.29B n/a n/a 18.03M
Cost & Expenses
143.09M 54.12M 65.06M 53.58M
Income Tax Expense
282.2K 94.39K 36.37K 4.75K
Shares Outstanding (Basic)
62.87M 49.12M 29.36M 7.84M
Shares Outstanding (Diluted)
62.87M 49.12M 29.36M 7.84M
EPS (Basic)
-1.89 -0.73 -2.2 -6.84
EPS (Diluted)
-1.89 -0.73 -2.2 -6.84
EBITDA
-119.58M -54.11M -65.05M -53.63M
EBIT
-120.96M -54.12M -65.06M -53.64M
Depreciation & Amortization
1.39M 13.16K 12.36K 4.97K